Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
Merck
Baxter
Boehringer Ingelheim

Last Updated: January 27, 2023

Vilazodone hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for vilazodone hydrochloride and what is the scope of patent protection?

Vilazodone hydrochloride is the generic ingredient in two branded drugs marketed by Allergan, Accord Hlthcare, Alembic Pharms Ltd, Invagen Pharms, and Teva Pharms Usa, and is included in five NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Vilazodone hydrochloride has sixty patent family members in twenty-nine countries.

There are twelve drug master file entries for vilazodone hydrochloride. Nine suppliers are listed for this compound.

Recent Clinical Trials for vilazodone hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Alliance on Mental Illness Westside Los Angeles
National Alliance on Mental Illness
Risk Benefit Statistics LLC

See all vilazodone hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for vilazodone hydrochloride
Paragraph IV (Patent) Challenges for VILAZODONE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VIIBRYD Tablets vilazodone hydrochloride 10 mg, 20 mg, and 40 mg 022567 5 2015-01-21

US Patents and Regulatory Information for vilazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208200-002 Apr 7, 2021 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Allergan VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-002 Jan 21, 2011 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Alembic Pharms Ltd VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208202-003 Jan 10, 2020 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Allergan VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-001 Jan 21, 2011 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for vilazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-001 Jan 21, 2011 See Plans and Pricing See Plans and Pricing
Allergan VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-002 Jan 21, 2011 See Plans and Pricing See Plans and Pricing
Allergan VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-003 Jan 21, 2011 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for vilazodone hydrochloride

Country Patent Number Title Estimated Expiration
Cyprus 1109447 See Plans and Pricing
Poland 364576 See Plans and Pricing
Japan 2010132688 POLYMORPHIC FORM OF 1-4-(5-CYANOINDOL-3-YL)BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE HYDROCHLORIDE See Plans and Pricing
Ecuador SP044943 FORMAS POLIMORFICAS DEL CLORHIDRATO DE 1-[4-5(5-CIANOINDOL-3-IL)BUTIL]-4-(2-CARBAMOILBENZOFURAN-5-IL)PIPERAZINA See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Baxter
Merck
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.